Qiagen acquires DNA-biometrics agency Verogen in $150 million deal
(Reuters) – Life sciences agency Qiagen stated on Monday it has acquired DNA-biometrics agency Verogen in a $150-million money deal, strengthening its forensics portfolio.
The deal builds on the businesses’ current partnership from 2021, beneath which Qiagen has the rights to distribute a few of Verogen’s merchandise comparable to its next-generation gene sequencing panels and genetic code analyzing expertise GEDmatch.
Qiagen expects about $20 million of gross sales from the Verogen portfolio this 12 months. The deal is predicted to be dilutive to Qiagen’s 2023 adjusted revenue per share by about 3 cents and impartial to the agency’s 2024 revenue.
San Diego-based Verogen, based in 2017, supplies DNA-based human identification services and products, that are utilized in forensic evaluation and to assist resolve prison and lacking individuals circumstances.
Verogen’s portfolio will complement Qiagen’s pattern assortment and preparation kits, that are used to separate human DNA from forensic investigation samples for evaluation.
(Reporting by Bhanvi Satija in Bengaluru; Modifying by Shailesh Kuber)
#Qiagen #acquires #DNAbiometrics #agency #Verogen #million #deal